| S2 Resources Limited (S2R) ORDINARY FULLY PAID |
Materials |
$34 |
Drill Testing of Multi-element Soil Anomaly, West Murchison
|
28 Aug 2025 9:34AM |
$0.120 |
$0.064 |
fallen by
46.67%
|
|
S2R - Price-sensitive ASX Announcement
Full Release
Key Points
- S2 Resources Limited has started drill testing at West Murchison in Western Australia.
- The drill program targets a strong multi-element soil anomaly (copper, gold, arsenic).
- Soil geochemical surveys identified a significant anomaly with potential for mineralization.
- The initial drilling comprises approximately 2,500 meters of reverse circulation (RC) drilling.
- The aim is to test the core of the anomaly for economic mineralization.
- Drilling results will guide future exploration programs.
- The project is strategically located and represents an opportunity for new discovery.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Terra Critical Minerals Limited (T92) ORDINARY FULLY PAID |
Energy |
$10 |
Terra Appoints USA Technical Advisor
|
28 Aug 2025 9:34AM |
$0.045 |
$0.068 |
risen by
51.11%
|
|
| Sequoia Financial Group Ltd (SEQ) ORDINARY FULLY PAID |
Financials |
$25 |
Appendix 4E and Annual Report 2025
|
28 Aug 2025 9:34AM |
$0.300 |
$0.200 |
fallen by
33.33%
|
|
SEQ - Price-sensitive ASX Announcement
Full Release
Key Points
- Appendix 4E and Annual Report for the year ended 30 June 2025 presented for Sequoia Financial Group Ltd.
- Comprehensive review of financial results, including revenues, profits, and loss figures.
- Details of principal business activities and significant changes during the reporting period.
- Discussion of dividends paid or recommended and their implications.
- Analysis of the operating environment, including economic and regulatory factors affecting performance.
- Description of business segments and strategic initiatives undertaken.
- Governance structures, risk management, and compliance practices detailed.
- Summary of remuneration for directors and key management personnel.
- Disclosures on related party transactions and financial statement notes.
- Plans for future growth, investment in technology, and ongoing focus on client service.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Siren Gold Limited (SNG) ORDINARY FULLY PAID |
Materials |
$24 |
$4.0M Raise to Fire Exploration Momentum
|
28 Aug 2025 9:34AM |
$0.062 |
$0.081 |
risen by
30.65%
|
|
| Clinuvel Pharmaceuticals Limited (CUV) ORDINARY FULLY PAID |
Health Care |
$462 |
Appendix 4E and Annual Report to Shareholders 2025
|
28 Aug 2025 9:34AM |
$13.550 |
$9.170 |
fallen by
32.32%
|
|
CUV - Price-sensitive ASX Announcement
Full Release
Key Points
- Provides the statutory Appendix 4E and Annual Report for Clinuvel Pharmaceuticals Limited for the financial year ended 30 June 2025.
- Summarizes financial performance including revenues, profits, expenses, and earnings per share.
- Highlights business achievements such as product launches, regulatory submissions, and pipeline progress.
- Details the company’s global expansion and commercial strategies.
- Covers key research and development initiatives in pharmaceuticals and photomedicine.
- Discusses corporate governance practices, risk management, and board activities.
- Explains dividend policy, shareholder returns, and financial outlook.
- Affirms the company’s focus on treating rare diseases and advancing photomedicine innovation.
- Includes commentary from senior management and the Board regarding strategic direction and operational priorities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Inghams Group Limited (ING) ORDINARY FULLY PAID |
Consumer Staple |
$676 |
Change of Director's Interest Notice - M Haseltine
|
28 Aug 2025 9:33AM |
$2.770 |
$1.820 |
fallen by
34.30%
|
|
| Comms Group Ltd (CCG) ORDINARY FULLY PAID |
Communication Services |
$38 |
FY25 results presentation
|
28 Aug 2025 9:33AM |
$0.060 |
$0.070 |
risen by
16.67%
|
|
CCG - Price-sensitive ASX Announcement
Full Release
Key Points
- CCG released its FY25 results presentation, reporting on financial and operational performance.
- The company maintains a focus on organic growth and operational efficiency.
- Key strategic initiatives include technology platform enhancement and streamlined processes.
- The FY25 outlook includes revenue and EBITDA guidance reflecting market opportunities and cost control.
- CCG emphasizes shareholder value creation through disciplined investment and innovation.
- Customer segments, go-to-market strategies, and business drivers are outlined for the year ahead.
- The presentation highlights CCG’s positioning in the communications and technology sector.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Moho Resources NL (MOH) ORDINARY FULLY PAID |
Materials |
$9 |
Moho stakes new gold project in the Pilbara WA
|
28 Aug 2025 9:33AM |
$0.005 |
$0.009 |
risen by
80%
|
|
MOH - Price-sensitive ASX Announcement
Full Release
Key Points
- Moho Resources NL has entered into an agreement to acquire 85% of the Peak Charles Gold Project in Western Australia.
- The project covers 805 square kilometers in the southern Pilbara Craton.
- Historical data and geophysical surveys indicate strong gold mineralisation potential.
- Moho plans an exploration program including geochemical sampling, geophysical surveys, and reconnaissance drilling.
- The acquisition is part of Moho’s strategy to expand its gold exploration portfolio in Western Australia.
- Key factors for acquisition include the project's strategic location, underexplored nature, and promising geology.
- Details of the agreement, planned exploration activities, and rationale are provided in the announcement.
- Consideration for the acquisition and Moho’s exploration approach are outlined.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| De.mem Limited (DEM) ORDINARY FULLY PAID |
Utilities |
$25 |
Appendix 4D and Half Yearly Report and Accounts
|
28 Aug 2025 9:33AM |
$0.105 |
$0.076 |
fallen by
27.62%
|
|
DEM - Price-sensitive ASX Announcement
Full Release
Key Points
- De.mem Limited achieved a 33% revenue increase for H1 2023 compared to H1 2022.
- Gross profit margin remained steady at 31%.
- EBITDA improved by 37% over the previous corresponding period.
- Net loss after tax was $1.61 million for the half year.
- Strong cash balance at the end of the reporting period.
- Growth was driven across all business units, with Chemicals and Membrane Systems performing strongly.
- Continued focus on higher-margin products and solutions.
- Investment in R&D and expansion of product portfolio.
- No dividends were paid or declared for the reporting period.
- The company is optimistic about continued growth into H2 2023.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Comms Group Ltd (CCG) ORDINARY FULLY PAID |
Communication Services |
$38 |
FY25 financial results announcement
|
28 Aug 2025 9:33AM |
$0.060 |
$0.070 |
risen by
16.67%
|
|
CCG - Price-sensitive ASX Announcement
Full Release
Key Points
- Comms Group Ltd released its FY25 financial results announcement.
- Summary of revenue performance, operational highlights, and year-on-year comparisons.
- Discussion of market trends affecting the communications industry.
- Details on strategic initiatives for sustainable growth and cost management.
- Update on key partnerships and business development activities.
- Management outlook for the next fiscal year and company priorities.
- Emphasis on technological innovation and competitive positioning.
- Commitment to shareholder value, corporate governance, and transparency.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pacgold Limited (PGO) ORDINARY FULLY PAID |
Materials |
$50 |
Compelling IP Gold Target Delineated at White Lion Prospect
|
28 Aug 2025 9:32AM |
$0.060 |
$0.115 |
risen by
91.67%
|
|
PGO - Price-sensitive ASX Announcement
Full Release
Key Points
- Pacgold Limited announced new high-resolution IP geophysical survey results at White Lion Prospect.
- Multiple strong IP chargeability and resistivity anomalies have been identified, considered compelling gold targets.
- The anomalies coincide with significant surface geochemistry and geological mapping results.
- White Lion Prospect is now a priority exploration target within the Alice River Gold Project.
- Drill testing of these targets is planned to commence in the coming quarter.
- Results support Pacgold’s growth strategy to expand its gold resources.
- The announcement underscores the prospectivity and exploration upside at White Lion based on integrated geophysical and geological data.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| archTIS Limited (AR9) ORDINARY FULLY PAID |
Information Technology |
$30 |
Completion of Placement & Institutional Entitlement Offer
|
28 Aug 2025 9:32AM |
$0.185 |
$0.062 |
fallen by
66.49%
|
|
AR9 - Price-sensitive ASX Announcement
Full Release
Key Points
- archTIS Limited completed an institutional placement and entitlement offer raising approximately AUD $6.3 million.
- The combined capital raising aims for a total of up to AUD $10 million.
- The funds will be used for working capital and growth initiatives.
- The placement and entitlement offer were well supported by institutional investors.
- A retail entitlement offer will follow, giving eligible retail shareholders the opportunity to participate.
- The offer price per new share was set at AUD $0.025.
- The capital raising is expected to strengthen archTIS's balance sheet and support its strategic goals.
- Settlement and allotment dates for the new shares are provided in the timetable.
- archTIS received strong support from both new and existing investors.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Beam Communications Holdings Limited (BCC) ORDINARY FULLY PAID |
Information Technology |
$5 |
Full Year FY2025 Result Reports & Appendix 4E
|
28 Aug 2025 9:32AM |
$0.130 |
$0.061 |
fallen by
53.08%
|
|
BCC - Price-sensitive ASX Announcement
Full Release
Key Points
- Beam Communications Holdings Limited (BCC) released its Appendix 4E and Full Year Results for the FY2025.
- The company reported a strong financial performance for the period, noting increased revenues compared to the prior year, attributed to higher sales of Iridium satellite communication devices and accessories.
- Operating profit improved, driven by enhanced sales performance, cost management, and product mix optimization.
- BCC highlighted significant progress in international markets, particularly in North America and Asia, contributing to the overall revenue growth.
- During the year, new product development initiatives and the launch of the Iridium GO! exec device supported continued business expansion.
- The company delivered positive cash flow from operations and maintained a solid balance sheet position.
- BCC’s focus remained on innovation and diversification, with investments in R&D and the development of advanced satellite communication solutions.
- Management emphasized its commitment to shareholder value and outlined strategies for sustainable growth, including further market penetration and strengthening distribution partnerships.
- The Board of Directors did not declare a final dividend for the year, as resources are being prioritized for growth initiatives.
- The outlook for FY2026 remains positive, with ongoing demand for satellite communications and the introduction of new products expected to support further growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Betmakers Technology Group Ltd (BET) ORDINARY FULLY PAID |
Consumer Discretionary |
$202 |
Appendix 4G
|
28 Aug 2025 9:32AM |
$0.150 |
$0.180 |
risen by
20%
|
|
| FOS Capital Ltd (FOS) ORDINARY FULLY PAID |
Industrials |
$9 |
FOS Capital DRP Plan AUG 2025
|
28 Aug 2025 9:32AM |
$0.300 |
$0.125 |
fallen by
58.33%
|
|
| Patrys Limited (PAB) ORDINARY FULLY PAID |
Health Care |
$20 |
Application for quotation of securities - PAB
|
28 Aug 2025 9:31AM |
$0.002 |
$0.030 |
risen by
1,900%
|
|
| Paladin Energy Ltd (PDN) ORDINARY FULLY PAID |
Energy |
$5,379 |
FY2025 Results Presentation
|
28 Aug 2025 9:31AM |
$7.510 |
$11.970 |
risen by
59.39%
|
|
| Westgold Resources Limited (WGX) ORDINARY FULLY PAID |
Materials |
$5,064 |
Final Dividend Declared for FY25 and On-Market Share Buyback
|
28 Aug 2025 9:31AM |
$3.370 |
$5.360 |
risen by
59.05%
|
|
WGX - Price-sensitive ASX Announcement
Full Release
Key Points
- Final dividend of 3 cents per share declared for FY25 with a payout ratio of 78%.
- The total dividend payout is $28.3 million, to be paid on 10 October 2025.
- The ex-dividend date is 11 September 2025, and the record date is 12 September 2025.
- Westgold Board has approved an on-market share buy-back program of up to 5% of Westgold shares over the next 12 months.
- The share buy-back reflects confidence in the company's ability to generate future cash flows and return capital to shareholders.
- Record gold production of 326,000 ounces was achieved in FY25.
- Enhanced capital management programme includes an increase in minimum dividend per share from 1 cent to 2 cents for FY26.
- The required minimum net cash balance increased from $100M to $150M after dividend payments for FY26.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Westgold Resources Limited (WGX) ORDINARY FULLY PAID |
Materials |
$5,064 |
Final Dividend Declared for FY25 and On-Market Share Buyback
|
28 Aug 2025 9:31AM |
$3.370 |
$5.360 |
risen by
59.05%
|
|
WGX - Price-sensitive ASX Announcement
Full Release
Key Points
- Final dividend of 3cps declared for FY25.
- Dividend payout ratio of 78%.
- Total dividend of $28.3M to be paid out on 10 October 2025.
- On-market Share Buy-Back of up to 5% approved for the next 12 months.
- FY26 dividend policy enhances minimum dividend to 2cps.
- Minimum net cash balance requirement increased to $150M for FY26.
- FY25 marked a transformational year with record gold production.
- Westgold's stock deemed materially undervalued.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Austral Gold Limited (AGD) ORDINARY FULLY PAID |
Materials |
$94 |
Austral Gold Announces Filing of 2025 Half Year Report
|
28 Aug 2025 9:31AM |
$0.044 |
$0.140 |
risen by
218.18%
|
|
AGD - Price-sensitive ASX Announcement
Full Release
Key Points
- Announced filing of 2025 Half Year Report for the period ended 31 December 2023
- Provided operational updates on Guanaco-Amancaya and Casposo-Manantiales projects
- Detailed gold and silver production figures and operational performance
- Disclosed financial results including revenues, EBITDA, profit/loss, and cash flow
- Highlighted ongoing exploration efforts and cost management strategies
- Discussed impact of commodity price fluctuations and operational challenges
- Outlined future plans for mine expansion and resource development
- Included governance, risk management, and auditor’s review statements
- Confirmed compliance with financial reporting standards and regulations
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Rhythm Biosciences Limited (RHY) ORDINARY FULLY PAID |
Health Care |
$50 |
Strategic partnership with Know Your Lemons Foundation
|
28 Aug 2025 9:31AM |
$0.100 |
$0.140 |
risen by
40%
|
|
RHY - Price-sensitive ASX Announcement
Full Release
Key Points
- Rhythm Biosciences Limited announced a strategic partnership with Know Your Lemons Foundation.
- Know Your Lemons Foundation is a global leader in breast cancer education with programs in over 100 countries.
- The partnership aims to increase awareness and education for breast cancer.
- RHY will leverage the Foundation’s campaigns and educational reach to support early detection.
- The collaboration aligns with both organizations’ missions to advance women’s health.
- Benefits include increased exposure for RHY’s diagnostic products and enhanced educational outreach for Know Your Lemons Foundation.
- The partnership is positioned to add value by merging RHY’s diagnostics expertise with the Foundation’s education efforts.
- The announcement underscores both parties’ roles in improving breast cancer outcomes through awareness and innovation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Starpharma Holdings Limited (SPL) ORDINARY FULLY PAID |
Health Care |
$299 |
$3.7M R&D Tax Incentive Received
|
28 Aug 2025 9:30AM |
$0.130 |
$0.710 |
risen by
446.15%
|
|
SPL - Price-sensitive ASX Announcement
Full Release
Key Points
- Starpharma Holdings Limited (ASX: SPL) announced the receipt of a $3.7 million Research and Development (R&D) Tax Incentive Refund.
- The refund is related to eligible R&D activities conducted during the 2023 financial year.
- These activities focused primarily on Starpharma’s proprietary dendrimer product portfolio, including its VIRALEZE™ antiviral nasal spray, DEP® drug delivery platform, and other pharmaceutical development programs.
- The R&D Tax Incentive is a program provided by the Australian Government to encourage companies to engage in R&D that benefits Australia.
- The received funds will support Starpharma’s ongoing research, development, and commercialization initiatives.
- Starpharma’s CEO, Dr. Jackie Fairley, stated that the refund will assist in advancing the company’s product pipeline, particularly in clinical trials and regulatory submissions.
- The announcement reiterates Starpharma’s commitment to innovation and development of novel pharmaceutical products.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Energy One Limited (EOL) ORDINARY FULLY PAID |
Information Technology |
$454 |
Change in substantial holding - BW South Asia
|
28 Aug 2025 9:30AM |
$14.200 |
$14.430 |
risen by
1.62%
|
|
| Platinum Capital Limited (PMC) ORDINARY FULLY PAID |
Financials |
- |
Update - Notification of buy-back - PMC
|
28 Aug 2025 9:29AM |
$1.510 |
$1.765 |
risen by
16.89%
|
|
| Arika Resources Limited (ARI) ORDINARY FULLY PAID |
Materials |
$30 |
Proposed issue of securities - ARI
|
28 Aug 2025 9:29AM |
$0.041 |
$0.026 |
fallen by
36.59%
|
|
Call 1300 880 160
Start a chat
Schedule a call
